Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Flow Property Evaluation of Powders – V 2.0

Posted on By

Analytical Method Development: SOP for Flow Property Evaluation of Powders – V 2.0

Standard Operating Procedure for Flow Property Evaluation of Powders in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/294/2025
Supersedes SOP/AMD/294/2022
Page No. Page 1 of 10
Issue Date 21/05/2025
Effective Date 23/05/2025
Review Date 21/05/2026

1. Purpose

To define the procedure for evaluating the flow properties of pharmaceutical powders and granules using established parameters such as angle of repose, compressibility index, and Hausner ratio, ensuring

batch suitability for tableting and encapsulation.

2. Scope

This SOP is applicable to the Analytical Method Development and Quality Control departments for routine assessment of powder flow characteristics during formulation development and commercial manufacturing.

3. Responsibilities

  • Formulation Scientist: Supplies powder samples and defines critical process parameters.
  • Analytical Scientist/QC Analyst: Performs and records flow property evaluations.
  • QA Executive: Verifies documentation and ensures compliance with specifications.
See also  Analytical Method Development: SOP for Preservative Quantification Method Development - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring validated flow property testing procedures are used to support quality and processing consistency.

5. Procedure

5.1 Angle of Repose

  1. Use a fixed funnel method on a flat surface.
  2. Allow powder to flow through a funnel positioned at a fixed height (6 cm) above the surface.
  3. Measure height (h) and radius (r) of the cone formed.
  4. Calculate angle of repose using the formula:
    θ = tan⁻¹(h/r)
  5. Perform the test in triplicate and report average.

5.2 Bulk and Tapped Density

  1. Weigh 50 g of powder and pour into a 100 mL graduated cylinder without compacting.
  2. Record initial volume as bulk volume (Vb).
  3. Tap the cylinder 500 times using a tapped density tester or manually, until volume stabilizes (Vt).
  4. Calculate:
    • Bulk density (g/mL) = Weight / Vb
    • Tapped density (g/mL) = Weight / Vt
See also  Analytical Method Development: SOP for Documentation Practices in Laboratory Notebooks - V 2.0

5.3 Compressibility Index and Hausner Ratio

  1. Calculate Compressibility Index (%) using:

    CI = [(Tapped density – Bulk density) / Tapped density] × 100
  2. Calculate Hausner Ratio using:

    HR = Tapped density / Bulk density

5.4 Interpretation of Flow Property

Test Excellent Good Fair Poor
Angle of Repose < 25° 25–30° 31–35° > 40°
Compressibility Index < 10% 11–15% 16–20% > 25%
Hausner Ratio < 1.11 1.12–1.18 1.19–1.25 > 1.34

6. Abbreviations

  • CI: Compressibility Index
  • HR: Hausner Ratio
  • θ: Angle of Repose
  • Vb: Bulk Volume
  • Vt: Tapped Volume

7. Documents

  1. Flow Property Test Sheet – Annexure-1
  2. Density Calculation Log – Annexure-2
  3. Statistical Summary Report – Annexure-3

8. References

  • USP <1174>: Powder Flow
  • Ph. Eur. 2.9.36: Powder Flow Properties
  • ICH Q6A: Specifications – Test Procedures and Acceptance Criteria

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Shweta Nair Prakash Chauhan Sunita Reddy
Designation Analytical Chemist QA Reviewer Head – AMD
Department Analytical Method Development QA Analytical Method Development

11. Annexures

Annexure-1: Flow Property Test Sheet

Sample ID Angle of Repose CI (%) HR Flow Grade
FP-294-01 28.4° 13.2% 1.15 Good

Annexure-2: Density Calculation Log

Weight (g) Bulk Volume (mL) Tapped Volume (mL) Bulk Density Tapped Density
50.0 72.5 63.0 0.69 g/mL 0.79 g/mL

Annexure-3: Statistical Summary Report

Powder exhibits acceptable flow properties with CI 13.2% and HR 1.15, suitable for tablet compression. Data within acceptable variation limits (RSD < 2%).

Revision History:

Revision Date Revision No. Details Reason Approved By
21/05/2025 2.0 Included interpretation table and detailed formulas Annual Review Sunita Reddy
20/09/2022 1.0 Initial SOP Release New SOP QA Head
See also  Analytical Method Development: Oxidation-Reduction Titration Development - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Failure to Integrate Validation Deviations into Final SOPs: A Common GMP Lapse
Next Post: Managing SOP Version Control Across Sites

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version